Literature DB >> 7532517

Physiology of the vas deferens.

W D Steers1.   

Abstract

Seminal emission occurs in response to rhythmic contractions of male secondary sex organs, including the vas deferens. Although contraction of the vas is directly due to adrenergic mechanisms, numerous substances modulate the release of norepinephrine from sympathetic pathways. These substances include local endogenous factors and neurotransmitters such as acetylcholine and NPY. Many substances are capable of altering the contractility of the vas deferens by modulating neural transmitter release or the basal tone of this smooth muscle. Because multiple pathways and substrates are capable of affecting its contractility, it is not surprising that drugs and metabolic disorders influence the function of the vas deferens and, ultimately, male fertility.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7532517     DOI: 10.1007/bf00191208

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  49 in total

1.  Distribution of calcitonin gene-related peptide-like immunoreactivity in various rat tissues: correlation with substance P and other tachykinins and sensitivity to capsaicin.

Authors:  P Geppetti; S Frilli; D Renzi; P Santicioli; C A Maggi; E Theodorsson; M Fanciullacci
Journal:  Regul Pept       Date:  1988-12

2.  Retroperitoneal lymphadenectomy for testis tumor with nerve sparing for ejaculation.

Authors:  M A Jewett; Y S Kong; S D Goldberg; J F Sturgeon; G M Thomas; R E Alison; M K Gospodarowicz
Journal:  J Urol       Date:  1988-06       Impact factor: 7.450

3.  Contraction-mediating alpha 2-adrenoceptors in the mouse vas deferens.

Authors:  R Bültmann; I von Kügelgen; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-06       Impact factor: 3.000

4.  Nucleotide modulation of norepinephrine release from sympathetic nerves in the rat vas deferens.

Authors:  K M Forsyth; R A Bjur; D P Westfall
Journal:  J Pharmacol Exp Ther       Date:  1991-03       Impact factor: 4.030

5.  Origin of neurons supplying the vas deferens of the rat.

Authors:  S C Kolbeck; W D Steers
Journal:  J Urol       Date:  1993-04       Impact factor: 7.450

6.  Structure-function studies on neuropeptide Y and pancreatic polypeptide--evidence for two PP-fold receptors in vas deferens.

Authors:  J C Jørgensen; J Fuhlendorff; T W Schwartz
Journal:  Eur J Pharmacol       Date:  1990-09-04       Impact factor: 4.432

7.  Prejunctional nicotinic receptors involved in facilitation of stimulation-evoked noradrenaline release from the vas deferens of the guinea-pig.

Authors:  L Todorov; K Windisch; H Shersen; A Lajtha; M Papasova; E S Vizi
Journal:  Br J Pharmacol       Date:  1991-01       Impact factor: 8.739

8.  Pre- and postjunctional effects of some prostanoids in human isolated vas deferens.

Authors:  F Holmquist; H Hedlund; K E Andersson
Journal:  Am J Physiol       Date:  1991-04

9.  A comparison of inhibitory effects of neuropeptide Y on rat urinary bladder, urethra, and vas deferens.

Authors:  J Zoubek; G T Somogyi; W C De Groat
Journal:  Am J Physiol       Date:  1993-09

10.  Effect of capsaicin on smooth muscles of rat vas deferens: involvement of calcitonin gene-related peptide?

Authors:  A Saito; Y Tomobe; K Goto
Journal:  J Pharmacol Exp Ther       Date:  1987-08       Impact factor: 4.030

View more
  7 in total

1.  Male contraception via simultaneous knockout of α1A-adrenoceptors and P2X1-purinoceptors in mice.

Authors:  Carl W White; Yan-Ting Choong; Jennifer L Short; Betty Exintaris; Daniel T Malone; Andrew M Allen; Richard J Evans; Sabatino Ventura
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-02       Impact factor: 11.205

2.  Opioid receptor characterisation of neuronally stimulated isolated human vas deferens.

Authors:  James Root; Ana Monica Lopes Correia Wakenhut; Holly Siggins; Sidath Katugampola; Carolyn Napier
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-06-15       Impact factor: 3.000

Review 3.  Phosphodiesterase 5 inhibitors in rapid ejaculation: potential use and possible mechanisms of action.

Authors:  Ibrahim A Abdel-Hamid
Journal:  Drugs       Date:  2004       Impact factor: 9.546

4.  Long-term use of sertraline leads to alterations in contractility of rat isolated vas deferens.

Authors:  Rasin Ozyavuz; Nuri Ihsan Kalyoncu; Seckin Karaoglu
Journal:  Urol Res       Date:  2003-10-25

5.  The effects of varicocele and its surgical correction on vas deferens motility.

Authors:  Arzu Demirtola; I Onur Ozen; Gokce S Ozturk; I Mert Vural; Sevim Ercan; Nuri Kale; Yusuf Sarioglu
Journal:  Pediatr Surg Int       Date:  2007-11-27       Impact factor: 1.827

6.  Effects of long-term treatment with haloperidol, clozapine and aripiprazole on mice isolated vas deferens.

Authors:  Mehmet Hanifi Tanyeri; Mehmet Emin Buyukokuroglu; Pelin Tanyeri; Oguz Mutlu; Füruzan Yildiz Akar; Güner Ulak; Bekir Faruk Erden
Journal:  Int Urol Nephrol       Date:  2017-07-03       Impact factor: 2.370

7.  Physiological and pharmacological aspects of the vas deferens-an update.

Authors:  David S Koslov; Karl-Erik Andersson
Journal:  Front Pharmacol       Date:  2013-08-22       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.